Baricitinib (Standard)

CAT:
804-HY-15315R-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Baricitinib (Standard) - image 1

Baricitinib (Standard)

  • Description:

    Baricitinib (Standard) is the analytical standard of Baricitinib. This product is intended for research and analytical applications. Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.
  • Product Name Alternative:

    LY3009104 (Standard) ; INCB028050 (Standard)
  • UNSPSC:

    12352005
  • Hazard Statement:

    H335-H360-H372
  • Target:

    JAK; Reference Standards
  • Type:

    Reference Standards
  • Related Pathways:

    Epigenetics; JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
  • Field of Research:

    Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/baricitinib-standard.html
  • Purity:

    99.86
  • Smiles:

    N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(S(=O)(CC)=O)C1
  • Molecular Formula:

    C16H17N7O2S
  • Molecular Weight:

    371.42
  • Precautions:

    P260-P264-P270-P271-P280-P403+P233-P405-P501
  • References & Citations:

    [1]Fridman JS, et al. Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050. J Immunol. 2010 May 1;184 (9) :5298-307.|[2]Jabbari A, et al. Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib. EBioMedicine. 2015 Feb 26;2 (4) :351-5.|[3]Khan IM, et al. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration resistance. Int J Obes (Lond) . 2015 Nov;39 (11) :1607-18.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -20°C, sealed storage, away from light and moisture
  • Scientific Category:

    Reference Standards
  • CAS Number:

    [1187594-09-7]